Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04560647 · ClinicalTrials.gov registry record
Pilot Studies Testing Levels of P63 in Psoriasis Skin Lesions
A clinical trial of Psoriasis, sponsored by Wright State University.
- Completed
- Registry status
- 9
- Enrollment target
- 1
- Study location
NCT04560647: Completed study of Psoriasis, sponsored by Wright State University.
NCT04560647 is a study of Psoriasis that has completed, run by Wright State University. The registered enrollment target is 9 participants, below the 489-participant average among 125 other Psoriasis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04560647, a study of Psoriasis, has completed, sponsored by Wright State University.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand the role of a specific protein, tumor protein p63 in the skin disease psoriasis. This study is to further understand how psoriasis lesions happens. An understanding of key mediators that lead to psoriasis might aid in the discovery of more effective treatments for this skin disorder. This is not an intervention study. The study is looking to obtain currently untreated plaque psoriasis biopsies and also biopsies from non psoriasis patients. Psoriasis and medical history will be collected then skin biopsies will be obtained from the subjects.
Primary Outcome
Determining if untreated psoriasis skin has abnormal p63 signaling
Conditions Studied
Interventions
- OTHER No intervention - Psoriasis Subject
- OTHER No intervention - Control Subject
Study Locations (1)
Ohio
- Wright State Physicians - Fairborn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-12-03 |
| Est. Completion | 2023-04-14 |
What the finished NCT04560647 record still lists
NCT04560647 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 489-participant average among 125 other Psoriasis trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Psoriasis appearing as the primary indexed condition, and to 2 interventions - of which No intervention - Psoriasis Subject is the first listed.
NCT04560647 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04560647 about?
NCT04560647 is a clinical study titled "Pilot Studies Testing Levels of P63 in Psoriasis Skin Lesions". The purpose of this study is to understand the role of a specific protein, tumor protein p63 in the skin disease psoriasis. This study is to further understand how psoriasis lesions happens. An understanding of key mediators that lead to psoriasis might aid in the discovery of more effective treatme...
What is the current status of trial NCT04560647?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2020-12-03. Estimated completion is 2023-04-14.
What conditions does trial NCT04560647 study?
This clinical trial studies the following conditions: Psoriasis.
What interventions are being tested in trial NCT04560647?
The interventions under investigation include: No intervention - Psoriasis Subject (OTHER), No intervention - Control Subject (OTHER).
Who is sponsoring clinical trial NCT04560647?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04560647 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psoriasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04560647's enrollment target sits among peer trials
9 122nd of 125 higher than 4 of 125 other Psoriasis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Psoriasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
RECRUITING · NA
-
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RECRUITING
-
Duobrii in Combination With Biologics
RECRUITING · Phase 4
-
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI